Literature DB >> 18367582

Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR.

Véronique Revaz1, Anne Debonneville, Martine Bobst, Denise Nardelli-Haefliger.   

Abstract

Monitoring of T-cell responses in genital mucosa has remained a major challenge because of the absence of lymphoid aggregates and the low abundance of T cells. Here we have adapted to genital tissue a sensitive real-time reverse transcription-PCR (TaqMan) method to measure induction of gamma interferon (IFN-gamma) mRNA transcription after 3 h of antigen-specific activation of CD8 T cells. For this purpose, we vaccinated C57BL/6 mice subcutaneously with human papillomavirus type 16 L1 virus-like particles and monitored the induction of CD8 T cells specific to the L1(165-173) H-2D(b)-restricted epitope. Comparison of the responses induced in peripheral blood mononuclear cells and lymph nodes (LN) by L1-specific IFN-gamma enzyme-linked immunospot assay and TaqMan determination of the relative increase in L1-specific IFN-gamma mRNA induction normalized to the content of CD8b mRNA showed a significant correlation, despite the difference in the readouts. Most of the cervicovaginal tissues could be analyzed by the TaqMan method if normalization to glyceraldehyde-3-phosphate dehydrogenase mRNA was used and a significant L1-specific IFN-gamma induction was found in one-third of the immunized mice. This local response did not correlate with the immune responses measured in the periphery, with the exception of the sacral LN, an LN draining the genital mucosa, where a significant correlation was found. Our data show that the TaqMan method is sensitive enough to detect antigen-specific CD8 T-cell responses in the genital mucosa of individual mice, and this may contribute to elaborate effective vaccines against genital pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367582      PMCID: PMC2394847          DOI: 10.1128/CVI.00392-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  25 in total

1.  Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory.

Authors:  D Homann; L Teyton; M B Oldstone
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

Review 2.  Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.

Authors:  Cassian Yee; Philip Greenberg
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

3.  Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa.

Authors:  Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.

Authors:  Isabelle Miconnet; Sylvain Koenig; Daniel Speiser; Arthur Krieg; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Intensity of the vaccine-elicited immune response determines tumor clearance.

Authors:  Ainhoa Perez-Diez; Paul J Spiess; Nicholas P Restifo; Polly Matzinger; Francesco M Marincola
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms.

Authors:  K Ghoshal; S Majumder; Q Zhu; J Hunzeker; J Datta; M Shah; J F Sheridan; S T Jacob
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.

Authors:  L Musey; Y Ding; J Cao; J Lee; C Galloway; A Yuen; K R Jerome; M J McElrath
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens.

Authors:  U S Kammula; K H Lee; A I Riker; E Wang; G A Ohnmacht; S A Rosenberg; F M Marincola
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

9.  Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine.

Authors:  A de Jong; T O'Neill; A Y Khan; K M C Kwappenberg; S E Chisholm; N R Whittle; J A Dobson; L C Jack; J A St Clair Roberts; R Offringa; S H van der Burg; J K Hickling
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

10.  Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Authors:  Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  10 in total

1.  CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model.

Authors:  Haruei Ogino; Kazuhiko Nakamura; Eikich Ihara; Hirotada Akiho; Ryoichi Takayanagi
Journal:  Dig Dis Sci       Date:  2010-06-03       Impact factor: 3.199

2.  Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.

Authors:  Sonia Domingos-Pereira; Rim Hojeij; Erica Reggi; Laurent Derré; Mathieu F Chevalier; Pedro Romero; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2015-05-22       Impact factor: 8.110

3.  Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Authors:  Loane Decrausaz; Sonia Domingos-Pereira; Mélanie Duc; Martine Bobst; Pedro Romero; John T Schiller; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

4.  Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.

Authors:  Claire Pieraerts; Virginie Martin; Patrice Jichlinski; Denise Nardelli-Haefliger; Laurent Derre
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

5.  IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women.

Authors:  Amre Nasr; Gamal Allam; Osama Hamid; Abdelhamid Al-Ghamdi
Journal:  Malar J       Date:  2014-08-13       Impact factor: 2.979

6.  Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.

Authors:  Laura Arribillaga; Iciar Echeverria; Viriginia Belsue; Timothy Gomez; Teresa Lozano; Noelia Casares; Lorea Villanueva; Sonia Domingos-Pereira; Pedro J Romero; Denise Nardelli-Haefliger; Sandra Hervás-Stubbs; Pablo Sarobe; María Josefa Rodriguez; José L Carrascosa; Thomas Zürcher; Juan José Lasarte
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

7.  Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors.

Authors:  Sonia Domingos-Pereira; Gabriele Galliverti; Douglas Hanahan; Denise Nardelli-Haefliger
Journal:  J Immunother Cancer       Date:  2019-05-06       Impact factor: 13.751

8.  Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model.

Authors:  Sonia Domingos-Pereira; Vincent Roh; Agnès Hiou-Feige; Gabriele Galliverti; Christian Simon; Genrich V Tolstonog; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2021-04-13       Impact factor: 8.110

9.  Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.

Authors:  S Domingos-Pereira; L Decrausaz; L Derré; M Bobst; P Romero; J T Schiller; P Jichlinski; D Nardelli-Haefliger
Journal:  Mucosal Immunol       Date:  2012-09-12       Impact factor: 7.313

10.  Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.

Authors:  Rim Hojeij; Sonia Domingos-Pereira; Marianne Nkosi; Dalila Gharbi; Laurent Derré; John T Schiller; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Int J Mol Sci       Date:  2016-07-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.